Schrödinger, Inc. (SDGR)

Schrödinger, Inc. is trading at $32.60, up 7.56% on the session. The 50 day average sits at $21.31 and the 200 day at $15.96, which puts the stock in a uptrend. RSI is at 69.9, which reads as strong, and MACD is bullish crossover. Volume is above average.

The nearest support is around $27.69 with resistance near $31.60, so that band frames the current range. Average daily movement is roughly $1.81, or about 5.5% of the share price, which is what any stop placement has to allow for. The overall health score of 75 out of 100 combines a trend score of 100, momentum of 88 and a risk score of 18.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.